Correlation Between Anebulo Pharmaceuticals and Tempus AI,
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Tempus AI, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Tempus AI, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Tempus AI, Class, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Tempus AI, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Tempus AI,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Tempus AI,.
Diversification Opportunities for Anebulo Pharmaceuticals and Tempus AI,
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Anebulo and Tempus is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Tempus AI, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempus AI, Class and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Tempus AI,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempus AI, Class has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Tempus AI, go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Tempus AI,
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.6 times more return on investment than Tempus AI,. However, Anebulo Pharmaceuticals is 1.6 times more volatile than Tempus AI, Class. It trades about -0.03 of its potential returns per unit of risk. Tempus AI, Class is currently generating about -0.56 per unit of risk. If you would invest 140.00 in Anebulo Pharmaceuticals on September 24, 2024 and sell it today you would lose (15.00) from holding Anebulo Pharmaceuticals or give up 10.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Anebulo Pharmaceuticals vs. Tempus AI, Class
Performance |
Timeline |
Anebulo Pharmaceuticals |
Tempus AI, Class |
Anebulo Pharmaceuticals and Tempus AI, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Anebulo Pharmaceuticals and Tempus AI,
The main advantage of trading using opposite Anebulo Pharmaceuticals and Tempus AI, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Tempus AI, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempus AI, will offset losses from the drop in Tempus AI,'s long position.Anebulo Pharmaceuticals vs. Fate Therapeutics | Anebulo Pharmaceuticals vs. Sana Biotechnology | Anebulo Pharmaceuticals vs. Caribou Biosciences | Anebulo Pharmaceuticals vs. Arcus Biosciences |
Tempus AI, vs. Regeneron Pharmaceuticals | Tempus AI, vs. AmTrust Financial Services | Tempus AI, vs. Encore Capital Group | Tempus AI, vs. Ardelyx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
CEOs Directory Screen CEOs from public companies around the world |